SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue for the quarter ended December 2021 remained nearly unchanged at Rs. 20330.54 millions.A slim rise of 24.01% was recorded in the Net profit for the quarter ended December 2021 to Rs. 5485.19  millions  From Rs. 4423.25 millions.The company reported a good operating profit of 7272.25 millions compared to 6113.63 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 20330.54 19724.78 3.07 63560.37 57175.65 11.17 75679.33 67126.31 12.74
Other Income 2167.43 811.27 167.17 4356.47 2793.80 55.93 3962.37 6067.88 -34.70
PBIDT 7272.25 6113.63 18.95 19622.83 18137.15 8.19 22865.78 19110.18 19.65
Interest 497.72 830.41 -40.06 1620.32 2033.91 -20.33 2658.98 2563.90 3.71
PBDT 6774.53 5742.24 17.98 22305.84 16842.16 32.44 20945.72 16731.82 25.18
Depreciation 407.98 412.12 -1.00 1179.23 1138.15 3.61 1508.15 1385.38 8.86
PBT 6366.55 5330.12 19.44 21126.61 15704.01 34.53 19437.57 15346.44 26.66
TAX 881.36 906.87 -2.81 3204.69 2627.25 21.98 2943.10 1800.96 63.42
Deferred Tax -525.12 -25.16 1987.12 -503.44 -119.64 320.80 -493.08 -891.41 -44.69
PAT 5485.19 4423.25 24.01 17921.92 13076.76 37.05 16494.47 13545.48 21.77
Equity 282.17 282.17 0.00 282.17 282.17 0.00 282.17 282.17 0.00
PBIDTM(%) 35.77 30.99 15.41 30.87 31.72 -2.68 30.21 28.47 6.13

Glenmark Pharma Share Price

2247.90 -1.65 (-0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×